These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28121538)

  • 1. Value Tools Not in The Insurer Toolkit-Yet.
    Silverman E
    Manag Care; 2016 Oct; 25(10):16-17. PubMed ID: 28121538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost of Cancer Drugs: Something Has To Give.
    Bender E
    Manag Care; 2018 May; 27(5):18-22. PubMed ID: 29763403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The economics of drug discovery and the ultimate valuation of pharmacotherapies in the marketplace.
    Sollano JA; Kirsch JM; Bala MV; Chambers MG; Harpole LH
    Clin Pharmacol Ther; 2008 Aug; 84(2):263-6. PubMed ID: 18547999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Just what the HMO ordered: the paradox of increasing drug costs.
    Kleinke JD
    Health Aff (Millwood); 2000; 19(2):78-91. PubMed ID: 10718024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No rational theory for drug pricing.
    Cox MC; Figg WD; Thurman PW
    J Clin Oncol; 2004 Mar; 22(5):962-3. PubMed ID: 14990657
    [No Abstract]   [Full Text] [Related]  

  • 7. Cancer drug prices and the free-market forces.
    Kantarjian H; Zwelling L
    Cancer; 2013 Nov; 119(22):3903-5. PubMed ID: 24037953
    [No Abstract]   [Full Text] [Related]  

  • 8. Market spiral pricing of cancer drugs.
    Light DW; Kantarjian H
    Cancer; 2013 Nov; 119(22):3900-2. PubMed ID: 24002792
    [No Abstract]   [Full Text] [Related]  

  • 9. Insurers, drugmakers wrestle with how to build value-based contracts.
    Herman B
    Mod Healthc; 2016 Feb; 46(8):12-3. PubMed ID: 27079043
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmaceutical funding decisions must balance therapeutic innovation, opportunity costs and patient equity.
    Ragupathy R; Jameson M
    N Z Med J; 2016 Aug; 129(1440):22-4. PubMed ID: 27538036
    [No Abstract]   [Full Text] [Related]  

  • 11. ASCO Rx for high drug costs: doctors and patients need to talk.
    Nicholas J
    J Natl Cancer Inst; 2009 Nov; 101(21):1441-4. PubMed ID: 19828870
    [No Abstract]   [Full Text] [Related]  

  • 12. Insurance loss leaves doctors scrambling for coverage. Insurer says it can no longer cover high-risk specialties.
    Lancet; 2003 Aug; 362(9381):376. PubMed ID: 12907022
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacoeconomics: the new dismal science.
    Luchins DJ
    Adm Policy Ment Health; 2004 May; 31(5):425-7. PubMed ID: 15379388
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug prices. In search of a fix.
    Bell H
    Minn Med; 2001 Jan; 84(1):24-8, 30-1. PubMed ID: 11202523
    [No Abstract]   [Full Text] [Related]  

  • 15. Changes to medicare part D: who benefits?
    DeMartino JK
    J Natl Compr Canc Netw; 2010 Sep; 8 Suppl 7():S4-6. PubMed ID: 20947723
    [No Abstract]   [Full Text] [Related]  

  • 16. Rising drug prices drive US manufacturers' revenues, analysis finds.
    McCarthy M
    BMJ; 2015 Oct; 351():h5376. PubMed ID: 26446098
    [No Abstract]   [Full Text] [Related]  

  • 17. Exploring the rise in American pharmaceutical prices.
    Marwaha A
    Pharos Alpha Omega Alpha Honor Med Soc; 2002; 65(2):11-5. PubMed ID: 12099112
    [No Abstract]   [Full Text] [Related]  

  • 18. Will lower drug prices jeopardize drug research? A policy fact sheet.
    Light DW; Lexchin J
    Am J Bioeth; 2004; 4(1):W1-4. PubMed ID: 15035915
    [No Abstract]   [Full Text] [Related]  

  • 19. Spending by Commercial Insurers on Chemotherapy Based on Site of Care, 2004-2014.
    Winn AN; Keating NL; Trogdon JG; Basch EM; Dusetzina SB
    JAMA Oncol; 2018 Apr; 4(4):580-581. PubMed ID: 29470578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. American pharmaceutical prices.
    Alagona P
    Pharos Alpha Omega Alpha Honor Med Soc; 2002; 65(4):58. PubMed ID: 12592980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.